Asensus Surgical, Inc.
ASXC · AMEX
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $79,625 | $82,086 | $251,926 | $44,610 |
| - Cash | $17,096 | $6,329 | $18,129 | $16,363 |
| + Debt | $5,682 | $5,538 | $5,689 | $2,815 |
| Enterprise Value | $68,211 | $81,295 | $239,486 | $31,062 |
| Revenue | $8,577 | $7,087 | $8,232 | $3,175 |
| % Growth | 21% | -13.9% | 159.3% | – |
| Gross Profit | -$4,578 | -$3,785 | -$2,864 | -$1,991 |
| % Margin | -53.4% | -53.4% | -34.8% | -62.7% |
| EBITDA | -$74,401 | -$64,287 | -$47,756 | -$47,110 |
| % Margin | -867.4% | -907.1% | -580.1% | -1,483.8% |
| Net Income | -$78,433 | -$75,561 | -$62,462 | -$59,312 |
| % Margin | -914.5% | -1,066.2% | -758.8% | -1,868.1% |
| EPS Diluted | -0.31 | -0.32 | -0.28 | -0.85 |
| % Growth | 3.1% | -14.3% | 67.1% | – |
| Operating Cash Flow | -$63,627 | -$58,937 | -$40,659 | -$46,675 |
| Capital Expenditures | -$561 | -$1,279 | -$1,368 | -$3 |
| Free Cash Flow | -$64,188 | -$60,216 | -$42,027 | -$46,678 |